Our products – FAQs
At Almirall, we are committed to ensuring safety, efficacy and accessibility while providing accurate product information for patients and healthcare professionals.
Frequently asked questions
Prescription medicines primarily in dermatology. Our portfolio is focused on treating a wide range of skin conditions, from common disorders to more complex inflammatory diseases.
Through scientific research, clinical testing and regulatory evaluation. Each medicine must demonstrate its safety, quality and effectiveness before it can be authorized for use.
Only a healthcare professional can advise whether a medicine is appropriate. They will consider your medical history, current treatments and specific needs before recommending any product.
Most require a prescription, depending on national regulation. Your doctor or pharmacist can inform you whether a particular medicine is available on prescription or over the counter in your country.
In some countries you may read about our products on the patient leaflet provided with your medicine. You may also find information in our local official medicine website. Always rely on official sources and consult your healthcare professional if you have any doubts.
We follow strict manufacturing standards and continuous quality control. Our facilities are regularly inspected, and our processes are designed to comply with international regulatory requirements.
Like all medicines, they may cause side effects, which are monitored closely. The most common and serious potential reactions are described in the product information, which should be reviewed with your healthcare professional. You may also report side effects directly to us.
Contact your healthcare professional and follow reporting instructions. They can advise on how to manage the reaction and, if necessary, adjust or stop the treatment.
Only your doctor or pharmacist can assess interaction risks. Always inform them about all medicines, supplements or herbal products you are taking before starting a new treatment.
Some may be authorized for paediatric use. The appropriate dose, formulation and age indication are detailed in each medicine’s prescribing information.
Availability and approved indications may vary based on regulation. Local health authorities decide which products are authorized and for which conditions they can be prescribed.
Pricing is regulated nationally; consult healthcare providers or pharmacies. They can inform you about reimbursement conditions, co-payments and any available alternatives.
We work to minimize environmental impact in manufacturing and packaging. This includes optimizing resource use, reducing waste and aligning with relevant environmental standards and regulations.
Development may take several years from research to clinical trial and approval. The exact timeline depends on the disease area, the complexity of the studies and regulatory requirements in each country.
Need to speak with our team?
For more information about our products, research, or strategic initiatives, please contact our Investor Relations team or our commercial and medical experts, who are available to assist with your enquiries.